Birmingham, West Midlands -- (SBWIRE) -- 01/14/2014 -- Value Penny Stocks issues special report on Palatin Technologies, Inc. (NYSEMKT:PTN), Northstar Realty Finance Corp. (NYSE:NRF), Athersys, Inc. (NASDAQ:ATHX), D.R. Horton, Inc. (NYSE:DHI).
Palatin Technologies, Inc. (NYSEMKT:PTN) ended its recent business day with the gain of 22.87% and closed at the price of $1.08 after opening at $1.00. The stock traded during its last trading session with the total volume of 2,532,636 shares, as compared to its average volume of 87,102.00 million shares. Palatin Technologies, Inc., a biopharmaceutical company, develops peptide therapeutics for the treatment of diseases. Its clinical development product is Bremelanotide, a peptide melanocortin receptor agonist that is in Phase III clinical trials for the treatment of female sexual dysfunction.
For How Long PTN will Fight for Profitability? Read This Trend Analysis report
Northstar Realty Finance Corp. (NYSE:NRF) remained among the day decliners and traded with volume of 6,890,065 shares in the last session, as compared to average volume of 11.85 million shares. In comparison with 52 week range of $7.38 - $14.27, it faced lowest price of $13.97 during the last trading session whereas its day highest price was $14.22. The company’s total market capitalization is $4.19 billion, along with 297.26 million shares outstanding. NorthStar Realty Finance Corp., a real estate investment trust (REIT), operates as a commercial real estate (CRE) investment and asset management company in the United States. It focuses on originating, structuring, acquiring, and managing senior and subordinate debt investments secured primarily by commercial, multifamily, and healthcare properties.
Has NRF Found The Bottom And Ready To Gain Momentum? Find Out Here
Athersys, Inc. (NASDAQ:ATHX) showed 2,529,208 shares in volume during the last trading session, while the average trading volume remained 2.13 million shares. The stock kicked off its trading session at $3.80 and closed at $4.10 after declining -2.50%. Athersys, Inc, a biotechnology company, focuses on the research and development in the field of regenerative medicine. The company’s lead platform product, MultiStem, an allogeneic stem cell product, which was evaluated in two completed Phase I clinical trials and is under two ongoing Phase II clinical trials for treating a range of diseases and various application in the field of clinical regenerative medicine.
Why Should Investors Buy ATHX After the Recent Fall? Just Go Here and Find Out
D.R. Horton, Inc. (NYSE:DHI) stock traded during its last trading session with the total traded volume of 6,779,995 shares versus its average volume of 6.26 million shares. The company opened its trade at the price of $21.97 and its closing price was $21.55 after losing -2.71% for the day. D.R. Horton, Inc. operates as a homebuilding company. It is engaged in the acquisition and development of land; and construction and sale of residential homes in 27 states and 78 markets in the United States under the D.R. Horton, America?s Builder, Emerald Homes, and Breland Homes.
Will DHI Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)